Skip to main content
Erschienen in: Critical Care 5/2014

Open Access 01.10.2014 | Letter

Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief

verfasst von: Pietro Caironi, Luciano Gattinoni

Erschienen in: Critical Care | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

No abstract.
Literatur
1.
Zurück zum Zitat Flannery AH, Kane SP, Coz-Yataco AO: A word of caution regarding proposed benefits of albumin from ALBIOS: a dose of healthy skepticism. Crit Care. 2014, 18: 509-10.1186/s13054-014-0509-x.PubMedCentralCrossRef Flannery AH, Kane SP, Coz-Yataco AO: A word of caution regarding proposed benefits of albumin from ALBIOS: a dose of healthy skepticism. Crit Care. 2014, 18: 509-10.1186/s13054-014-0509-x.PubMedCentralCrossRef
2.
Zurück zum Zitat Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L: Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014, 370: 1412-1421. 10.1056/NEJMoa1305727.CrossRef Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L: Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014, 370: 1412-1421. 10.1056/NEJMoa1305727.CrossRef
3.
Zurück zum Zitat Quinlan GJ, Martin GS, Evans TW: Albumin: biochemical properties and therapeutic potential. Hepatology. 2005, 41: 1211-1219. 10.1002/hep.20720.CrossRef Quinlan GJ, Martin GS, Evans TW: Albumin: biochemical properties and therapeutic potential. Hepatology. 2005, 41: 1211-1219. 10.1002/hep.20720.CrossRef
4.
Zurück zum Zitat Caironi P, Gattinoni L: The clinical use of albumin: the point of view of a specialist in intensive care. Blood Transfus. 2009, 7: 259-267.PubMedCentral Caironi P, Gattinoni L: The clinical use of albumin: the point of view of a specialist in intensive care. Blood Transfus. 2009, 7: 259-267.PubMedCentral
5.
Zurück zum Zitat O’Brien AJ, Fullerton JN, Massey KA, Auld G, Sewell G, James S, Newson J, Karra E, Winstanley A, Alazawi W, Garcia-Martinez R, Cordoba J, Nicolaou A, Gilroy DW: Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2. Nat Med. 2014, 20: 518-523. 10.1038/nm.3516.CrossRef O’Brien AJ, Fullerton JN, Massey KA, Auld G, Sewell G, James S, Newson J, Karra E, Winstanley A, Alazawi W, Garcia-Martinez R, Cordoba J, Nicolaou A, Gilroy DW: Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2. Nat Med. 2014, 20: 518-523. 10.1038/nm.3516.CrossRef
6.
Zurück zum Zitat Caironi P, Tognoni G, Gattinoni L: Albumin replacement in severe sepsis or septic shock. N Engl J Med. 2014, 371: 84-10.1056/NEJMc1405198.CrossRef Caironi P, Tognoni G, Gattinoni L: Albumin replacement in severe sepsis or septic shock. N Engl J Med. 2014, 371: 84-10.1056/NEJMc1405198.CrossRef
Metadaten
Titel
Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief
verfasst von
Pietro Caironi
Luciano Gattinoni
Publikationsdatum
01.10.2014
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 5/2014
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-014-0510-4

Weitere Artikel der Ausgabe 5/2014

Critical Care 5/2014 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.